DuPont Beats on Q3 Sales and EPS, Raises 2026 Profit Outlook
DD sits 45% above its 52-week low of $100.005.
Summary
DuPont beat on every line in Q3: sales of $1.87 bln topped the $1.84 bln consensus, adjusted EPS of $2.09 crushed the $1.87 estimate and rose 62% year over year, and operating EBITDA of $469 mln beat $449.40 mln at a 25.1% margin. Mid-single-digit organic growth in Healthcare & Water Technologies and Diversified Industrials drove the top line, while higher segment earnings plus lower interest expense, tax rate and share count lifted EPS. Management raised full-year 2026 adjusted EPS guidance to $7.47-$7.52 and sees operating EBITDA of about $1.785 bln. The company also completed a $250 mln accelerated share buyback and plans another $250 mln in Q4, on top of the buybacks announced with Q1 and Q2. Q4 guidance calls for adjusted EPS of $1.90-$1.95 on net sales of about $1.825 bln.
At the time of this announcement, DD was trading at $144.76 on NYSE in the Manufacturing sector, with a market capitalization of approximately $19.1B. The 52-week trading range was $100.01 to $157.98. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.